Physician profile
James Christopher Fleming
NPI 1447234893
$6,677.61
in general payments reported to CMS, 2019-2025
37 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $481 · 2021: $994 · 2022: $677 · 2023: $925 · 2024: $1,168 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,711.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,403.78 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $894.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $560.32 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $500.42 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.97 | 2019-2025 | Jardiance |
| Abbvie INC. | $354.59 | 2019-2025 | |
| Lilly USA, LLC | $344.31 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $293.02 | 2019-2025 | Repatha, Otezla, Otezla |
| Exact Sciences Corporation | $251.39 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $184.04 | 2021-2022 | |
| Eisai INC. | $182.40 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2025 | Voquezna |
| Esperion Therapeutics, INC. | $122.61 | 2021-2025 | Nexletol |
| Amarin Pharma, INC. | $122.25 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $114.46 | 2019-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fleming listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.